COSMOS Pharmaceutical Corporation (TYO:3349)

COSMOS Pharmaceutical Income Statement

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Revenue	1,042,629	1,011,390	964,989	827,697	755,414	726,424
Revenue Growth (YoY)	4.84%	4.81%	16.59%	9.57%	3.99%	6.14%
Cost of Revenue	822,540	798,109	776,683	658,979	603,966	581,313
Gross Profit	220,089	213,281	188,306	168,718	151,448	145,111
Selling, General & Admin	158,905	152,430	138,536	122,807	107,756	99,163
Operating Expenses	179,352	172,877	156,804	138,589	121,651	111,964
Operating Income	40,737	40,404	31,502	30,129	29,797	33,147
Interest Expense	-374	-254	-99	-51	-52	-60
Interest & Investment Income	72	48	44	47	52	57
Other Non Operating Income (Expenses)	2,882	2,961	2,852	2,960	3,063	2,690
EBT Excluding Unusual Items	43,317	43,159	34,299	33,085	32,860	35,834
Gain (Loss) on Sale of Assets	-	-	75	-	265	4,190
Asset Writedown	-374	-508	-1,010	-113	-70	-31
Other Unusual Items	-352	-280	355	-200	-8	-1,398
Pretax Income	42,591	42,371	33,719	32,772	33,047	38,595
Income Tax Expense	11,393	11,393	9,265	8,975	9,892	11,439
Net Income	31,198	30,978	24,454	23,797	23,155	27,156
Net Income to Common	31,198	30,978	24,454	23,797	23,155	27,156
Net Income Growth	14.30%	26.68%	2.76%	2.77%	-14.73%	26.69%
Shares Outstanding (Basic)	79	79	79	79	79	79
Shares Outstanding (Diluted)	79	79	79	79	79	79
Shares Change (YoY)	-	0.02%	0.05%	-	-	-
EPS (Basic)	393.63	390.85	308.61	300.48	292.37	342.89
EPS (Diluted)	393.63	390.85	308.61	300.48	292.37	342.89
EPS Growth	14.30%	26.65%	2.71%	2.77%	-14.73%	26.69%
Free Cash Flow	-462	-859	-635	7,798	-11,303	1,811
Free Cash Flow Per Share	-5.83	-10.84	-8.01	98.46	-142.72	22.87
Dividend Per Share	37.500	70.000	60.000	50.000	40.000	35.000
Dividend Growth	-40.00%	16.67%	20.00%	25.00%	14.29%	27.27%
Gross Margin	21.11%	21.09%	19.51%	20.38%	20.05%	19.98%
Operating Margin	3.91%	4.00%	3.26%	3.64%	3.94%	4.56%
Profit Margin	2.99%	3.06%	2.53%	2.88%	3.06%	3.74%
Free Cash Flow Margin	-0.04%	-0.08%	-0.07%	0.94%	-1.50%	0.25%
EBITDA	64,099	62,633	51,426	47,497	44,907	46,932
EBITDA Margin	6.15%	6.19%	5.33%	5.74%	5.95%	6.46%
D&A For EBITDA	23,362	22,229	19,924	17,368	15,110	13,785
EBIT	40,737	40,404	31,502	30,129	29,797	33,147
EBIT Margin	3.91%	4.00%	3.26%	3.64%	3.94%	4.56%
Effective Tax Rate	26.75%	26.89%	27.48%	27.39%	29.93%	29.64%
Advertising Expenses	-	1,561	1,812	1,648	1,632	2,784

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.